PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.32%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.39%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-399.43%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-4.34%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-714.16%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-713.16%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-713.16%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.00%
Slight or no buybacks while 1475.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.24%
Negative OCF growth while 1475.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
45.21%
FCF growth of 45.21% while 1475.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
178562.95%
10Y revenue/share CAGR above 1.5x 1475.HK's 39.58%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
178.11%
5Y revenue/share CAGR above 1.5x 1475.HK's 26.71%. David Dodd would look for consistent product or market expansions fueling outperformance.
28.80%
Positive 3Y CAGR while 1475.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
366.34%
Positive long-term OCF/share growth while 1475.HK is negative. John Neff would see a structural advantage in sustained cash generation.
321.78%
Positive OCF/share growth while 1475.HK is negative. John Neff might see a comparative advantage in operational cash viability.
216.09%
3Y OCF/share CAGR of 216.09% while 1475.HK is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
79.08%
Net income/share CAGR above 1.5x 1475.HK's 22.87% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
83.79%
5Y net income/share CAGR above 1.5x 1475.HK's 28.81%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-129.55%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-35.33%
Negative equity/share CAGR over 10 years while 1475.HK stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
23.77%
5Y equity/share CAGR above 1.5x 1475.HK's 6.35%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-0.97%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.18%
Inventory is declining while 1475.HK stands at 7.62%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.13%
Positive asset growth while 1475.HK is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.66%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-7.72%
We’re deleveraging while 1475.HK stands at 2.39%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while 1475.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-2.08%
We cut SG&A while 1475.HK invests at 10.39%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.